Personalized arts prescriptions for behavioral health challenges in the US
Award amount
$241,102Program and phase
SBIR · Phase IAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SOCIALRX INC
- Proposal award date
- 2024-09-04
- Contract end date
- 2025-08-31
- UEI
- ZNQ8C5U8QMY9
- Solicitation number
- PA23-230
- Topic code
- NCCIH
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Using scalable ultrasonic nano-emulsification to improve pharmacokinetic properties of the natural product curcumin.
- Botanical Drug for Chemotherapy Induced Nausea and Vomiting
- Leveraging Large Scale Bioinformatics and AI for Natural Product Drug Discovery and Target Selection
- Evaluation of a novel soil-derived Mycobacterium as a nutritional supplement to promote stress resilience
Research funding history
2 SBIR/STTR records share this UEI (2024–2025). Reported award amounts total $535,022. Reported amounts are not federal obligations.
Phases: Phase I
Agencies: Department of Health and Human Services